Growth Metrics

Sarepta Therapeutics (SRPT) Share-based Compensation Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 206.26%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -69.95%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.18%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.66%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 23.70%
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn -18.72%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -18.72%
Dec 31, 2025 -35.24%
Sep 30, 2025 -62.31%
Jun 30, 2025 -26.73%
Mar 31, 2025 -8.36%
Dec 31, 2024 53.96%
Sep 30, 2024 -9.56%
Jun 30, 2024 6.54%
Mar 31, 2024 9.59%
Dec 31, 2023 -9.30%
Sep 30, 2023 -4.60%
Jun 30, 2023 -53.93%
Mar 31, 2023 41.28%
Dec 31, 2022 69.60%
Sep 30, 2022 88.83%
Jun 30, 2022 254.80%
Mar 31, 2022 2.45%
Dec 31, 2021 0.86%
Sep 30, 2021 -0.75%
Jun 30, 2021 5.01%
Mar 31, 2021 18.63%
Dec 31, 2020 33.59%
Sep 30, 2020 30.60%
Jun 30, 2020 39.74%
Mar 31, 2020 49.22%
Dec 31, 2019 72.52%
Sep 30, 2019 79.13%
Jun 30, 2019 29.16%
Mar 31, 2019 52.95%
Dec 31, 2018 73.92%
Sep 30, 2018 66.14%
Jun 30, 2018 512.00%
Mar 31, 2018 84.28%
Dec 31, 2017 7.24%
Sep 30, 2017 -27.69%
Jun 30, 2017 -63.40%
Mar 31, 2017 -14.62%
Dec 31, 2016 8.21%
Sep 30, 2016 68.45%
Jun 30, 2016 15.18%
Mar 31, 2016 -52.74%
Dec 31, 2015 10.07%
Sep 30, 2015 22.24%
Jun 30, 2015 6.14%
Mar 31, 2015 226.02%
Dec 31, 2014 57.96%
Sep 30, 2014 33.32%
Jun 30, 2014 141.03%
Mar 31, 2014 159.84%
Dec 31, 2013 194.91%
Sep 30, 2013 403.90%
Jun 30, 2013 426.82%
Mar 31, 2013 136.02%
Dec 31, 2012 83.41%
Sep 30, 2012 16.89%
Jun 30, 2012 -38.63%
Mar 31, 2012 -38.17%
Dec 31, 2011 7.31%
Sep 30, 2011 16.31%